Latest Regulatory Relief News

Diamond Infraco, backed by IFM Global Infrastructure Fund, has won ASIC approval to extend its Atlas Arteria takeover offer if certain ownership thresholds are met late in the bid period, potentially reshaping the contest timeline.

Saluda Medical’s Australian arm has secured ASIC approval to bypass standalone audited financial reports, cutting costs and streamlining compliance.

Vulcan Energy’s Lionheart Project in Rhineland-Palatinate will benefit from a five-year royalty exemption on lithium production, reinforcing Germany’s push for domestic critical material supply and boosting the project’s economic outlook.

Kjerulf David Hastings Ainsworth has issued a first supplementary statement for his second off-market takeover bid targeting 5.5% of Ainsworth Game Technology shares at $1.30 each, revealing an 8.24% voting stake ahead of the offer’s close.

Shriro Holdings Limited has announced a $15 million off-market share buy-back at $0.81 per share, representing nearly 26% of its issued capital. The move aims to return excess capital to shareholders while supporting the company’s capital-light growth model.

The Federal Court of Australia has approved key restructuring schemes for Global Uranium and Enrichment Limited, paving the way for streamlined shareholder arrangements and regulatory exemptions in multiple jurisdictions.

Bellavista Resources Ltd has agreed to acquire a majority stake in the high-grade Pickle Crow Gold Project in Ontario, Canada, boasting a 2.8 million ounce inferred resource at 7.2g/t gold. The company is also raising up to A$25 million to fund aggressive exploration and development.

Bellavista Resources Ltd has agreed to acquire up to 80% of the Pickle Crow Gold Project in Ontario, Canada, adding a 2.8 million ounce inferred gold resource at 7.2g/t to its portfolio. The company is raising A$25 million to fund aggressive exploration and development activities.

Brightstar Resources has completed its acquisition of Aurumin Limited, converting Aurumin shares and options into Brightstar securities and prompting Aurumin’s imminent delisting from the ASX.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Pro-Pac Packaging has entered voluntary administration, securing relief to defer its financial reporting and annual general meeting obligations for up to two years. This move pauses key corporate governance duties as the company navigates its restructuring.

Aurumin Limited has obtained ASIC approval to extend its 2025 AGM deadline, aligning with the proposed acquisition by Brightstar Resources. This move sets the stage for a significant ownership change pending shareholder approval.